MAPT and Cognitive impairment: Across all cognitively unimpaired (CU) individuals and patients with mild cognitive impairment (MCI), SMOC1 and ITGAM showed the strongest positive associations with global Aβ-PET levels (Fig. 3a), all associations being independent of tau-PET levels.